+2348068528936
EDE, NIGERIA, November 2024.
The Institute of Genomics and Global Health (IGH) – formerly known as African Centre of Excellence for Genomics of Infectious Diseases (ACEGID) at Redeemer’s University, successfully sequenced the entire human genome for the first time on Nigerian soil. This was also the first human genome sequence in Africa using Illumina’s NovaSeqTM X Plus sequencer.
This momentous milestone comes at the time of the official opening of the Genomics and Bioinformatics Training Academy within IGH at Redeemer’s University. This facility will significantly increase the supply of qualified technical workforce for next-generation sequencing wet lab management, bioinformatics, big data analytics and advanced artificial intelligence/machine learning applications.
Despite Africa being the birthplace of humanity and harbouring immense genetic diversity, less than 2% of human genomes sequenced and analyzed so far have been from the African people.1
Using Illumina’s NovaSeqTM X Plus sequencer, more than 20,000 whole human genomes can be sequenced per year. This is 2.5 times the output of NovaSeqTM 6000.
“Successfully sequencing a whole human genome at the Institute of Genomics and Global Health is a significant milestone, as from here we will be able to grow our understanding of genetic diversity and ancestry of African populations, which is currently underrepresented in genomic research,” said Dr Happi, Founder and Director of IGH.
The Institute of Genomics and Global Health has successfully sequenced 11 human samples on the NovaSeq X plus and analysed them on the Illumina DRAGEN secondary analysis platform. All samples passed the threshold for a high quality human whole genome equivalent.
Including diverse African populations, can create inclusive and relevant scientific knowledge which challenges potential historical bias in medical research.
“This groundbreaking achievement marks a significant step forward in our understanding of genetic diversity and ancestry of African populations and human genetics in general,” said Gregory Essert, Illumina’s General Manager of Emerging Markets.
The Institute of Genomics and Global Health and Illumina entered a partnership agreement to establish a genomics training academy at Redeemer’s University in 2023. The delivery of the first Illumina NovaSeqTM X Plus in Africa to the IGH last year was an important milestone to embedding genomics capability within Africa.
The IGH is a global hub of excellence for genomic research, and it is leading the way in using genomics to improve public health in Africa. The procurement of the NovaSeq X Plus by the IGH is a testament to the institute’s commitment to scientific innovation and changing the narratives about science in Africa. Genomics is rapidly transforming the way we diagnose and treat diseases, and it has the potential to revolutionize healthcare in the continent.
“Sequencing capacity developed at the Institute of Genomics and Global Health opens doors to personalized and precision medicine, targeted therapies, and disease prevention. It empowers our local scientists to study genetic factors related to non-communicable diseases prevalent in African populations,” Dr Happi said.
The partnership between IGH and Illumina will enable early access to Illumina’s high-throughput sequencing, allowing African researchers in life sciences, oncology, reproductive health, agriculture and other emerging fields to rapidly decode DNA and advance our understanding of genetics and diseases.
With this new major milestone, IGH, Redeemer’s University, is becoming a global leader in DNA sequencing and array-based technologies, and will be playing a pivotal role in advancing genomics research and personalized medicine in Africa.
Reference
1 https://www.sciencedirect.com/science/article/pii/S2666979X23000381
About IGH
The Institute of Genomics and Global Health (formerly African Centre of Excellence for Genomics of Infectious Diseases was founded in 2014 to train the next generation of African genomic scientists, to help understand circulating health threats, and facilitate effective, evidence-based outbreak preparedness and response using One Health approach. The Institute’s research portfolio now extends to human genome research and precision medicine, data science and virtual reality, among others.
To learn more, visit www.acegid.org and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, and YouTube.
Media Contact: in*********@ru*.ng
